The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so ...

Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs ...

The alleged violations occurred before Pfizer bought Biohaven and its migraine treatment three years ago for $11.6 billion.

Over the years, the U.S. Department of Justice (DOJ) has taken a host of drugmakers to task over alleged kickback payments ...

Pfizer has agreed to pay $60 million to resolve allegations brought by the US government that its Biohaven Pharma subsidiary ...

Biohaven wielded meals at high-end restaurants and paid speaking opportunities to induce healthcare providers to prescribe ...

Pfizer will pay nearly $60 million to settle allegations that Biohaven, a company it acquired, paid kickbacks to healthcare ...

"Patients deserve to know that their doctor is prescribing medications ... said in a statement. Nurtec ODT, also known as Rimegepant, was approved for treating acute migraine in February 2020 ...

Pfizer ended the Nurtec speaker programs after paying $11.5 billion to buy Biohaven in October 2022. "Patients deserve to know that their doctor is prescribing medications based on their doctor's ...